Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Sui’s Post-Mortem Leaves Recovery Questions as AlphaPepe Builds The Next x100 Case
-
As Global Markets Discover Elektros, Microcap and Penny Stock Investors Are Beginning To Take Notice of a Growing EV Patent Technology and Lithium Mining Company
-
Diana Shipping Inc. Sends Letter to Genco Shipping & Trading Shareholders Making the Case for Electing Six Independent Nominees With Proven Track Records of Creating Shareholder Value
-
Diana Shipping Inc. Sends Letter to Genco Shipping & Trading Shareholders Making the Case for Electing Six Independent Nominees With Proven Track Records of Creating Shareholder Value
-
Next Crypto To Explode: AlphaPepe Gains Attention While Bitcoin Stalls and Degens Chase Fresh Narratives
-
Best Crypto To Buy Now: AlphaPepe Becomes the June Wildcard as Bitcoin ETF Demand Cools
-
Bitcoin Price Prediction: Strategy Pauses Buying as AlphaPepe Becomes the Retail Wildcard
-
UGRO: urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 Player Auction Set for June 1, 2026 @ 5:00 AM EDT (2:30 PM Colombo Time)
-
Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?
-
GROK87K Token: Launching Into the AI‑Crypto Era — Presale Now Live
-
MedHugs Announces Development of Oral Thin Film Vitamin Strip Addressing Pill Swallowing Challenges
-
Pierre Protas Announces Five New Collections Defining Identity Driven Fashion Design
-
Cow Wings Expands BC Meat Delivery Service
-
CGTN: China-Africa ties at 70: From shared struggles to a common dream of modernization
-
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
-
Top Crypto to Buy in 2026? APEMARS Sparks 916% ROI Surge With LAUNCH350 Bonus Offer As BNB News Momentum And Stellar Growth Trends
-
Hyperliquid (HYPE) Whales Took Profit, But AlphaPepe Is Where Smaller-Cap Hunters Are Looking Next
-
Best Crypto Presale Right Now: Why Buyers Are Hunting AlphaPepe Before the June Rotation
-
essentL PEO Adds Workers Comp and HR Compliance in 50-State Rollout
-
Always A Sweep Shares Florida Gas Appliance Safety Tips for Homeowners
-
Power Wash Ocala Explains Why Florida Siding Turns Black & Green
-
Shell Card Program Adds Zapier Push Integration
-
Los Angeles CPA Firm Adds 12-Scenario FIRPTA Guide
-
Public-Private Partnerships Are Returning, But the Next Model Must Be Built Around Execution
-
Sublime AI Law Mastery Unveiled to Resolve Historic Camp Lejeune Backlog (Veterans First For America)
-
Thatched-Roof Tiki Boats Now Available for Private Charters in Fort Lauderdale
-
Portugal Pathways Reports Steady Buyer Interest in 2026
-
AI Data Centers Are Creating a New Infrastructure Finance Cycle, and Power Is the Real Constraint
-
Stone Realty Group Analysis Finds Charlotte Housing Market Is Splitting Into Distinct Buyer and Seller Micro-Markets
-
Kulani Kinis Makes Miami Swim Week Debut with "Endless" Runway Experience and SOJOS Eyewear Collaboration
-
United Imaging Spotlights Molecular Imaging Showstoppers at SNMMI 2026
-
"NINJA BASKETBALL ARMY" Unveiled: A New Story-Driven Brand Officially Inspired by the NBA
-
GROK37K The real way to get 200% bonus tokens
-
GRABAR LAW OFFICE INVESTIGATES CLAIMS ON BEHALF OF SHAREHOLDERS OF ZOETIS, INC. (ZTS)
-
CPKC to maintain rail operations across Canada during IBEW strike
-
KALDVIK AS (KLDVK): Q1 2026 Quarterly Update
-
Liuuve AI Dropshipping combines AI live streaming with a global supply chain to make selling smarter and starting a business simpler
-
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
-
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMON
-
Private Credit Is Moving Into Infrastructure Finance, But Discipline Will Decide the Winners
-
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
-
Village Voyage: Where China's rural soul meets the world
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
-
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
-
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradi
-
How McKinney Plans for 400,000 Residents and a 24/7 Digital Ecosystem
-
Epure Millwork Launches Design-trade Studio Service, Giving AD100 Architects and Interior Designers a Dedicated Custom Millwork Partner for the Northeast
-
AI Is Reshaping Crypto Faster Than Anyone Expected as AIX Alpha’s New System Signals the Shift
-
Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic
